Graduated in Pharmacy at the Federal University of Ouro Preto (2015). attended Improvement I at the National Cancer Institute (INCA) in 2016; is Master in Oncology from the same institution (2019), where she is currently a PhD student, working on topics as epigenetics, molecular biology and genetics in pediatric solid tumors, with a primary focus on Wilms tumors. Currently, she is also doing a specialization in hospital pharmacy and oncologic monitoring (ICTQ).
Possui graduação em Farmácia pela Universidade Federal de Ouro Preto (2015). Cursou Aperfeiçoamento I no Instituto Nacional do Câncer (INCA) em 2016, e concluiu o Mestrado (2019) e Doutorado (2022) em Oncologia pela mesma instituição, trabalhando com temas como epigenética, biologia molecular e genética em tumores sólidos pediátricos, com foco principal em tumores de Wilms. Especialista em Farmácia hospitalar e acompanhamento oncológico (ICTQ - 2021).
